MB BS, FRCP (Edin), FRCP (UK)
I have been a Consultant in Diabetes, Endocrinology and General Internal Medicine at Mid Yorkshire Teaching NHS Trust since 2006, having received my specialist training in Nottingham and Derby. I have had extensive clinical experience in all aspects of specialist Diabetes and Endocrinology and have held several important clinical leadership roles to date.
I am the Head of Clinical Services at Mid Yorkshire Teaching Trust for Diabetes, Endocrinology and Weight Management services since 2022.
I also have academic roles including Honorary Senior Lecturer for University of Leeds School of Medicine and the Undergraduate Placement Lead for Diabetes and Endocrinology for Medical Students from Leeds University. I am also Regional Specialty Advisor for Diabetes & Endocrinology for the Royal College of Physicians.
I have an active clinical research interest and have been principal investigator for several multinational commercial and academic clinical trials in diabetes, cardiovascular medicine and diabetic foot disease.
Clinical Awards and Achievements
I have an active research interest and am an investigator for a number of commercial and academic clinical trials in diabetes, cardiovascular medicine and diabetic foot disease.
Some of my recent awards and achievements include: In recognition of my contribution to the development and delivery of local services I have achieved Local Clinical Excellence Award Level 5 in 2016. National Quality in Care Award (Highly commended; September 2015): I led on the development of a Local MDT Diabetic Foot Protection Team. This was set up to streamline patient referral pathways and minimise harmful delays in the patient journey.
Some of the principal treatments carried out by Dr Ryan D'Costa at Spire include:
Endocrinology and diabetes
General medicine
Other treatments
MB BS / Bangalore University, India / 1996
Bachelor of Medicine, Bachelor of Surgery
FRCP (Edin) / Edinburgh / 2015
Royal College of Physicians of Edinburgh
FRCP (UK) / England / 2015
Royal College of Physicians of England
Diabetes UK
Society of Endocrinology
Association of British Clinical Diabetologists
British Medical Association
Medical Protection Society
Clinical Lead for the Wakefield Diabetes Clinical Network
Diabetes UK Local Clinical Champion
Clinical Governance Lead for Diabetes and Endocrinology and Mid Yorkshire Hospitals
Undergraduate Placement Lead at Mid Yorkshire Hospitals for Diabetes and Endocrinology for Final Year Medical S
JAMA. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial.
01/01/2014
Lancet Diabetes Endocrinol. LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial.
01/01/2018
Wound Repair Regen. Multicentre, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study.
01/01/2018
Cardiovasc Diabetol. The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)
01/01/2022
Diabetes Care. Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.
01/01/2022
N Engl J Med. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
01/01/2023
Cost-effectiveness of swab versus tissue sampling for infected diabetic foot ulcers from the CODIFI2 randomised controlled trial.
01/01/2025
Consultant Physician in Diabetes and Endocrinology
In my free time I enjoy a spot of gardening and cooking exotic dishes. As a father of a 11 and a 13 year old I also run a demanding Dad's taxi service!